Selectivity for Omega-Receptor Subtypes as a Strategy for the Development of Anxiolytic Drugs - Langer, S Z; Arbilla, S; Tan, S; Lloyd, K G; George, P; Allen, J; Wick, A E (Pharmacopsychiatry, 1990)